GlassScriptPhysician profile
Jeanine Moreno
NPI 1629406483
$1,501.17
in general payments reported to CMS, 2019-2025
9 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $110 · 2023: $50.10 · 2024: $695 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $491.31 | 2021-2025 | Uzedy, Austedo Xr |
| Regeneron Healthcare Solutions, INC. | $227.91 | 2024 | Dupixent |
| Madrigal Pharmaceuticals | $145.18 | 2025 | Rezdiffra |
| Alnylam Pharmaceuticals INC. | $143.71 | 2025 | Onpattro |
| Novo Nordisk INC | $125.00 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.57 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $109.93 | 2022 | |
| Medtronic, INC. | $97.46 | 2024 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $50.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanine Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.